Global Diagnostic Enzymes Market by Type (Carbohydrases, Polymerases and Nucleases, Protease, Others), By Application (Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

The Global Diagnostic Enzymes Market size is projected to reach USD X.X billion by 2028 from USD 0.8 billion in 2016, growing at a CAGR of 12%. Factors such as the increasing adoption of molecular diagnostics and the rising prevalence of infectious diseases are driving the demand for diagnostic enzyme-based systems across various applications including biocatalysts, diagnostics, pharmaceuticals, and research & biotechnology.

The term “diagnostic enzymes” is also referred to as “analytical reagents” or more simply, diagnostic products. These are used in the diagnosis of various diseases and disorders by detecting chemical substances (e.g., proteins) present in body fluids such as blood, saliva, urine, etc. This helps healthcare professionals detect, prevent, and manage various diseases. Diagnostic enzymes are proteins that catalyze biochemical reactions. The properties of diagnostic enzymes include high specificity, efficiency, and tolerance to inhibitors, and extreme pH levels. These enzymes play a critical role in the diagnosis of various diseases by accelerating the chemical reaction rates and helping to identify the presence or absence of certain molecules in a sample. Additionally, they are also used in the production of biocatalysts, pharmaceuticals, and research & biotechnology products.

On the basis of Type, the global diagnostic enzymes market is segmented into Carbohydrases, Polymerases and Nucleases, Protease, and Others.

Carbohydrases:

Carbohydrases are enzymes that catalyze the hydrolysis of carbohydrates. The most common carbohydrase is alpha-amylase, which cleaves the maltose molecule into two glucose molecules. Other carbohydrases include beta-glucosidase, which breaks down complex sugars into simple sugars, and cellulose, which decomposes cellulose into glucose. Some properties of carbohydrases include: They are highly specific. They are not affected by pH changes in the environment. They are stable at high temperatures. Their activity is independent of metal ions and divalent cations. They are inexpensive to produce. Carbohydrases can be denatured at high pH, low temperature, and when exposed to heavy metal ions. Carbohydrases are useful in the food industry, by catalyzing disaccharide hydrolysis. They also play a role in digesting dietary fibers and starch to produce sugars.

Polymerases And Nucleases:

Polymerases and nucleases are enzymes that catalyze the polymerization or cleavage of DNA or RNA, respectively. These enzymes are essential for many biochemical processes, including DNA replication and transcription. Polymerases and nucleases can be used as diagnostic tools to detect genetic disorders or viral infections. They can also be used in research and biotechnology applications to produce recombinant DNA or RNA.

Protease:

Protease is an enzyme that catalyzes the hydrolysis of peptide bonds in proteins. Proteases are important for digestion, blood clotting, and the immune system. Some proteases are used in biotechnology and pharmaceutical production. For example, renin is a protease involved in the regulation of blood pressure. Pepsin and trypsin, produced by the stomach and pancreas respectively, are proteases used in indigestion.

Proteases are enzymes that catalyze the hydrolysis of proteins. The property of proteases to cleave peptide bonds in proteins results in their widespread use in research, diagnostics, and therapeutics. Proteases can be classified into several types according to their mechanism of action: serine proteases, cysteine proteases, metalloproteases, and aspartic proteases. Serine proteases are the most common type of protease and include trypsin, chymotrypsin, and elastase. Cysteine proteases include papain and bromelain. Metalloproteases include matrix metalloproteinases (MMPs) and tumor necrosis factor-alpha converting enzyme (TACE). Aspartic proteases include asparaginase. The activity of proteases can be inhibited by protease inhibitors, which are used in the treatment of diseases such as cancer, arthritis, and HIV/AIDS. Protease inhibitors include aprotinin, leupeptin, pepstatin, and antipain.

On the basis of Application, the global diagnostic enzymes market is segmented into Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology.

Biocatalysts:

Diagnostic enzymes are used as biocatalysts for various applications in the life sciences industry. They are used to catalyze chemical reactions and convert substrates into products. The use of diagnostic enzymes as biocatalysts provides several benefits such as high specificity, efficiency, and productivity. Additionally, they offer a better return on investment as compared to traditional chemical catalysts. The use of diagnostic enzymes as biocatalysts is expected to grow in the future owing to the increasing demand for better and faster diagnostics.

Diagnostics:

In the Diagnostics application, diagnostic enzymes are used in immunodiagnostic tests and enzyme-linked immunosorbent assays (ELISA). In ELISA, an analyte or ligand is immobilized on a selected surface. A biological sample containing the antigen of interest is added to this solid-phase substrate where it binds with its specific antibody that is immobilized on the surface. If present, the antigen will also bind with a second antibody that is conjugated to an enzyme. The enzymatic activity of this second antibody can then be detected and quantified. A number of diagnostic enzymes are used in ELISA tests for HIV, hepatitis C virus (HCV), herpes simplex virus (HSV), human chorionic gonadotropin (hCG), and other cancers.

Pharmaceuticals:

The use of diagnostic enzymes in the pharmaceutical industry is increasing day by day. The main reason for this is that the enzymes are very effective and efficient in breaking down the large molecules into small pieces. This helps in drug discovery and development by providing a better understanding of how a particular drug works. In addition, diagnostic enzymes are also used for manufacturing various drugs such as vaccines, hormones, and antibiotics. They are also used for the production of various therapeutic proteins. Thus, the use of diagnostic enzymes in the pharmaceutical industry is increasing at a rapid pace.

Research & Biotechnology:

Diagnostic enzymes are used in the research sector to develop new medicines. They are also widely used for diagnostics, health care, and healthcare management purposes. Diagnostic enzymes are used in the field of biotechnology to identify and diagnose diseases. The enzymes are also used for the production of pharmaceuticals and other products. They play an important role in research and development activities. Enzymes help researchers to study the genetic makeup of organisms. Biotech companies use diagnostic enzymes to develop new therapies and diagnostics for a wide range of diseases.

On the basis of Region, the global diagnostic enzymes market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Among these, the North American region is expected to hold the largest market size in 2018. The high disposable income and increasing healthcare expenditure are driving the growth for this region. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period. The growth in this region can be attributed to the rising geriatric population, growing prevalence of lifestyle diseases, and increasing demand for point-of-care diagnostics.

The increasing demand from emerging countries such as Argentina, Brazil, and Mexico has increased the uptake of these products among healthcare providers across Latin America. The market for diagnostic enzymes in Europe is expected to grow at a CAGR of around 20% during the forecast period. The increasing demand for diagnostic enzymes from the biotechnology and pharmaceutical industries is a major factor driving the market growth in this region. The growing focus on personalized medicine is also expected to boost the demand for diagnostic enzymes in Europe during the forecast period.

The market for diagnostic enzymes in the Middle East & Africa is expected to exhibit a CAGR of around 11.68% during 2015 – 2028. The demand for enzyme-based diagnostics will be driven by several factors such as increasing incidences of chronic diseases, growing awareness about disease prevention and early diagnosis among patients, government initiatives related to the healthcare sector, and rapid technological advancements in the field of diagnostics. The market for diagnostic enzymes is expected to witness significant growth in countries such as Saudi Arabia, UAE, South Africa, and Nigeria during the forecast period.

Growth Factors For The Global Diagnostic Enzymes Market:

There are a number of factors driving the growth in the diagnostic enzymes market. The growing trend towards personalized medicine is one such factor that has been fueling the demand for these enzyme reagents from both developed and emerging countries including North America, Asia Pacific, Latin America, and Europe over the past few years. Moreover, rapid advances in genetic engineering technology have allowed scientists to identify and isolate new enzymes, which is also projected to spur the demand for diagnostic enzymes over the forecast period. Additionally, rising incidences of infectious diseases and growing applications of diagnostics in food safety are some other key factors augmenting the growth of this market.

Up Market Research published a new report titled “Diagnostic Enzymes Market research report which is segmented by Types (Carbohydrases, Polymerases and Nucleases, Protease, Others), By Applications (Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology), By Players/Companies Spark Therapeutics, Genzyme, Aldevron, Kaneka Eurogentec, Biovian, Brammer, Cobra Biologics, FinVector Vision Therapies, Oxford Gene Technology, Vigene Biosciences”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Diagnostic Enzymes Market Report Segments:

The market is segmented by Type Carbohydrases, Polymerases and Nucleases, Protease, Others and By Application Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology.

Some of the companies that are profiled in this report are:

1. Spark Therapeutics
2. Genzyme
3. Aldevron
4. Kaneka Eurogentec
5. Biovian
6. Brammer
7. Cobra Biologics
8. FinVector Vision Therapies
9. Oxford Gene Technology
10. Vigene Biosciences

Diagnostic Enzymes Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Diagnostic Enzymes Market

Overview of the regional outlook of the Diagnostic Enzymes Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Diagnostic Enzymes Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Diagnostic Enzymes Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.
6. By Type:

                1. Carbohydrases

                2. Polymerases and Nucleases

                3. Protease

                4. Others

                1. Biocatalysts

                2. Diagnostics

                3. Pharmaceuticals

                4. Research & Biotechnology

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Diagnostic Enzymes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Diagnostic Enzymes Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.